TABLE 5.
The reactivity patterns of the indeterminate samples.
| Ind. pattern | INNO-LIA | WB reactivity | No. | qPCR results | No. of samples positive by the following assay/ | |||
| reactivity pattern | pattern | (positive no./tested no.) | total no. of samples tested: |
|||||
| Avioq | Murex | Roche | Fujirebio | |||||
| INNO-LIA±/WB− | gp21 I/II | / | 127 | 0/30 | 4/130 (0.3%) | 54/130 (41.53%) | 93/130 (71.5%) | 72/130 (55.38%) |
| p19 I/II, p24 I/II | / | 3 | NT | |||||
| INNO-LIA−/WB± | / | rgp46-II | 5 | NT | 2/15 (12.3%) | 8/15 (53.3%) | 9/15 (60.0%) | 5/15 (33.3%) |
| / | GD21 | 2 | ||||||
| / | p19 | 3 | ||||||
| p19 I/II | p19 | 1 | ||||||
| p19 I/II | p24 | 1 | ||||||
| p19 I/II | p19, p26 | 1 | ||||||
| / | rgp46-I | 1 | ||||||
| p24 I/II | p24, rgp46-I | 1 | ||||||
| INNO-LIA±/WB± | gp21 I/II | GD21 | 3 | NT | 0/6 (0.00%) | 4/6 (66.67%) | 4/6 (66.67%) | 5/6 (83.3%) |
| gp21 I/II | rgp46-I | 1 | ||||||
| gp21 I/II | rgp46-II | 1 | ||||||
| p19 I/II,p24 I/II | p19, p26 | 1 | ||||||
| Total | 151 | 0/30 | 6/151 (0.4%) | 66/151 (43.7%) | 103/151 (68.7%) | 82/151 (54.3%) | ||
LIA, line immunoassay; WB, western blot; ±, indeterminate; −, negative; NT, not tested.